You have 9 free searches left this month | for more free features.

21-135

Showing 1 - 25 of 8,649

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Painful Diabetic Neuropathy Trial (NRD135SE.1, Placebo)

Not yet recruiting
  • Painful Diabetic Neuropathy
  • (no location specified)
Aug 15, 2022

Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix

Active, not recruiting
  • Endometriosis
  • 75 mg linzagolix tablet
  • +5 more
  • Dothan, Alabama
  • +46 more
Jan 12, 2023

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Molar Incisor Hypomineralization Trial in Irbid (SDF, HVGIC restoration, SSC)

Recruiting
  • Molar Incisor Hypomineralization
  • SDF
  • +2 more
  • Irbid, Jordan
    Jordan University of Science and Technology
Mar 5, 2023

Meningitis, Meningococcal Meningitis, Meningococcal Infections Trial in Puerto Rico, United States (Meningococcal Polysaccharide

Completed
  • Meningitis
  • +2 more
  • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
  • Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined
  • Chandler, Arizona
  • +35 more
Mar 24, 2022

ADHD Trial in Columbus, Portland, Lethbridge (Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino

Completed
  • Attention Deficit Hyperactivity Disorder
  • Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants
  • Placebo
  • Columbus, Ohio
  • +2 more
Jan 13, 2022

Self Esteem Trial in Amsterdam (EsteemUp, EsteemUp-G)

Enrolling by invitation
  • Self Esteem
  • EsteemUp
  • EsteemUp-G
  • Amsterdam, Netherlands
    Vrije Universiteit Amsterdam
Nov 29, 2022

Migraine Without Aura, Migraine With Aura Trial in Worldwide (Placebo, Eletriptan HBr 40 mg, Eletriptan HBr 80 mg)

Completed
  • Migraine Without Aura
  • Migraine With Aura
  • Placebo
  • +2 more
  • Antwerpen, Belgium
  • +147 more
Jan 26, 2021

Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
  • Hyperlipidemia
  • Evolocumab
  • +6 more
  • Birmingham, Alabama
  • +243 more
Nov 4, 2022

Peripheral Arterial Disease Trial in Caen (transcutaneous oxygen pressure, Supervised Exercise therapy)

Recruiting
  • Peripheral Arterial Disease
  • transcutaneous oxygen pressure
  • Supervised Exercise therapy
  • Caen, Normandie, France
    CHU Caen Normandie
Apr 14, 2023

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Hyponatremia, Dengue, Inflammation Trial in Haedo, Buenos Aires (hyponatremia)

Recruiting
  • Hyponatremia
  • +2 more
  • hyponatremia
  • Haedo, Buenos Aires, Argentina
  • +1 more
Oct 31, 2023

Meningitis, Meningococcal Meningitis, Meningococcal Infections Trial in United States (Meningococcal Polysaccharide (A, C, Y,

Completed
  • Meningitis
  • +3 more
  • Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine
  • Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W 135 Combined
  • Chandler, Arizona
  • +11 more
Mar 24, 2022

Infection, Meningococcal Trial in Seoul (Meningococcal(Groups A, C, W-135, X, and Y) Conjugate Vaccine, Meningococcal(Groups A,

Not yet recruiting
  • Infection, Meningococcal
  • Meningococcal(Groups A, C, W-135, X, and Y) Conjugate Vaccine
  • Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 12, 2023

Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)

Recruiting
  • Type 1 Diabetes Mellitus
  • Vancouver, British Columbia, Canada
    Investigational Site Number : 1240001
Oct 31, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)

Completed
  • Pulmonary Arterial Hypertension
  • Riociguat (Adempas, BAY63-2521)
  • +2 more
  • Phoenix, Arizona
  • +80 more
Feb 3, 2021

NSCLC Trial in Worldwide (Osimertinib, Pemetrexed/Carboplatin, Pemetrexed/Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Bellflower, California
  • +154 more
Dec 23, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Multiple Myeloma
  • Plant based meals
  • Basking Ridge, New Jersey
  • +6 more
Apr 11, 2022

Pregnancy Trial in New York (StEP:Prenatal, Routine Care)

Not yet recruiting
  • Pregnancy
  • StEP:Prenatal
  • Routine Care
  • New York, New York
    NYC Health + Hospitals/Bellevue
Oct 19, 2023

A Prognostic Transcriptomic Signature for Chronic

Recruiting
  • Hypersensitivity Pneumonitis
    • Tucson, Arizona
    • +6 more
    Jan 9, 2023

    Cervical Cancer Trial in Chengdu (NACT, CCRT, Brachytherapy)

    Not yet recruiting
    • Cervical Cancer
    • Chengdu, Sichuan, China
      Sicchuan cancer hospital
    Dec 28, 2021

    Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)

    Active, not recruiting
    • Gastric Cancer
    • +2 more
    • BMS-986213
    • +4 more
    • Clovis, California
    • +77 more
    Jan 9, 2023

    Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in Worldwide (Selinexor (combination therapy), Placebo matching for

    Recruiting
    • Relapsed/Refractory Diffuse Large B-cell Lymphoma
    • Selinexor (combination therapy)
    • +7 more
    • Chandler, Arizona
    • +51 more
    May 6, 2022